Literature DB >> 9042399

Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene.

D I Rodenhiser1, J D Andrews, D N Mancini, J H Jung, S M Singh.   

Abstract

Neurofibromatosis type 1 (NF1) is among the most common human genetic disorders, having a constellation of cutaneous and skeletal manifestations, intellectual impairment, and an increased risk for a variety of malignancies. The NF1 gene has a high spontaneous mutation rate and is also associated with a variety of sporadic cancers in the general population. While a number of laboratories are involved in a coordinated effort to identify NF1 mutations, an important gap in our knowledge is an understanding of the mechanisms responsible for NF1 mutagenesis. In this present paper we describe our analysis of the sequence environment in the NF1 gene at those sites where small deletions, insertions and nucleotide substitution mutations have been reported. Our objective was to determine whether specific nucleotide sequences commonly occur at these mutation sites within the NF1 gene. We assessed how frequently independent NF1 mutations occur at the site of short direct repeats, single nucleotide repeats (homonucleotides) and at CpG and CpNpG motifs. We have established that homonucleotide and short direct repeats are commonly involved in the majority of small deletions and insertions analysed. Substitution mutations are frequently associated with homonucleotide repeats and methylatable CpG dinucleotides and CpNpG trinucleotides. We suggest that NF1 mutations are acquired and retained by cells through an intricate balancing of repair and replication mechanisms. Such mutations may provide a proliferative advantage for that cell and its progeny.

Entities:  

Mesh:

Year:  1997        PMID: 9042399     DOI: 10.1016/s0027-5107(96)00171-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

Review 2.  On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease.

Authors:  David N Cooper; Albino Bacolla; Claude Férec; Karen M Vasquez; Hildegard Kehrer-Sawatzki; Jian-Min Chen
Journal:  Hum Mutat       Date:  2011-09-02       Impact factor: 4.878

3.  PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.

Authors:  Inga Ebermann; Jennifer B Phillips; Max C Liebau; Robert K Koenekoop; Bernhard Schermer; Irma Lopez; Ellen Schäfer; Anne-Francoise Roux; Claudia Dafinger; Antje Bernd; Eberhart Zrenner; Mireille Claustres; Bernardo Blanco; Gudrun Nürnberg; Peter Nürnberg; Rebecca Ruland; Monte Westerfield; Thomas Benzing; Hanno J Bolz
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  Clinical and genetic studies of Birt-Hogg-Dubé syndrome.

Authors:  S K Khoo; S Giraud; K Kahnoski; J Chen; O Motorna; R Nickolov; O Binet; D Lambert; J Friedel; R Lévy; S Ferlicot; P Wolkenstein; P Hammel; U Bergerheim; M-A Hedblad; M Bradley; B T Teh; M Nordenskjöld; S Richard
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

5.  Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).

Authors:  D Mancini; S Singh; P Ainsworth; D Rodenhiser
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

6.  Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes.

Authors:  M Krawczak; E V Ball; D N Cooper
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

7.  Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides.

Authors:  David N Cooper; Matthew Mort; Peter D Stenson; Edward V Ball; Nadia A Chuzhanova
Journal:  Hum Genomics       Date:  2010-08       Impact factor: 4.639

Review 8.  Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?

Authors:  Anja Harder
Journal:  Childs Nerv Syst       Date:  2022-01-08       Impact factor: 1.475

9.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.